Vu Phan

TRIO-US B-12 TALENT: Phase II neoadjuvant trial evaluating trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early-stage breast cancer.

Sara A. Hurvitz, Lisa S. Wang, David W. Chan et al. · Journal of Clinical Oncology · 2022 · 39 citations

Medicine, Pharmacology, Chemotherapy +16

Abstract GS2-03: GS2-03 TRIO-US B-12 TALENT: Neoadjuvant trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early stage breast cancer

Aditya Bardia, Sara A. Hurvitz, Michael F. Press et al. · Cancer Research · 2023 · 31 citations

Medicine, Oncology, Pharmacology +17

Abstract P5-16-02: Updated efficacy, safety and translational data from MARIO-3, a phase II open-label study evaluating a novel triplet combination of eganelisib (IPI-549), atezolizumab (atezo), and nab-paclitaxel (nab-pac) as first-line (1L) therapy for locally advanced or metastatic triple-negative breast cancer (TNBC)

Soliman Hatem, Jeffrey B. Hargis, Anthony Elias et al. · Cancer Research · 2022 · 24 citations

Medicine, Oncology, Pharmacology +17

Effects of dual-tasking on time-to-boundary during stance in people with PD: A preliminary study

Daniel S. Peterson, Vu Phan, Sutton B. Richmond et al. · Clinical Biomechanics · 2021 · 17 citations

Education, Neurology, Psychology +11